NASDAQ:PHAS - PhaseBio Pharmaceuticals Earnings Date, Estimates & History

Sign in or create an account to add this stock to your watchlist.
$9.10 +2.25 (+32.85 %)
(As of 03/26/2019 04:00 PM ET)
Previous Close$6.85
Today's Range$6.85 - $9.17
52-Week Range$2.55 - $9.17
Volume444,883 shs
Average Volume178,993 shs
Market Capitalization$222.93 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Earnings

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Earnings History and Estimates Chart

Earnings by Quarter for PhaseBio Pharmaceuticals (NASDAQ:PHAS)

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Earnings Estimates

Current Year EPS Consensus Estimate: $-12.08 EPS
Next Year EPS Consensus Estimate: $-1.06 EPS

PhaseBio Pharmaceuticals (NASDAQ PHAS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/26/2019
(Confirmed)
 ($0.29)     After Market ClosesView Earnings Details
11/29/2018Q3($0.22)($10.45)($10.45)$0.41 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Featured Article: What is a Roth IRA?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel